Z-0860-2021 Class II Ongoing

Recalled by Medtronic Neuromodulation — Minneapolis, MN

FDA device recall Z-0860-2021 was initiated by Medtronic Neuromodulation on Nov 12, 2020 and is designated Class II. Reason for recall: A710 Intellis Clinician Application has a software issue that can result in the inability to program the Intellis implantable neurostimulation device. The recall status is ongoing. Affected quantity: 7960 downloads.

Recall details

Product Type
Devices
Report Date
Jan 20, 2021
Initiation Date
Nov 12, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7960 downloads

Product description

Medtronic Intellis Spinal Cord Stimulator, Model Number A710, Clinical Programmer application version 1.3.80 - Product Usage: intended for use by clinicians in the programming of the following Medtronic neurostimulators (external and implantable) for pain therapy.

Reason for recall

A710 Intellis Clinician Application has a software issue that can result in the inability to program the Intellis implantable neurostimulation device.

Distribution pattern

Worldwide distribution - US Nationwide distribution and the countries of Canada, Latin America, Asia Pacific, Japan, China, and European regions.

Code information

Software version 1.3.80

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0860-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0860-2021. Report a data issue: hello@regdatalab.com.